Authors:
Serretti, A
Zanardi, R
Rossini, D
Cusin, C
Lilli, R
Smeraldi, E
Citation: A. Serretti et al., Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity, MOL PSYCHI, 6(5), 2001, pp. 586-592
Authors:
Perez, J
Tardito, D
Racagni, G
Smeraldi, E
Zanardi, R
Citation: J. Perez et al., Protein kinase A and Rap1 levels in platelets of untreated patients with major depression, MOL PSYCHI, 6(1), 2001, pp. 44-49
Authors:
Franchini, L
Spagnolo, C
Rossini, D
Smeraldi, E
Bellodi, L
Politi, E
Citation: L. Franchini et al., A neural network approach to the outcome definition on first treatment with sertraline in a psychiatric population, ARTIF INT M, 23(3), 2001, pp. 239-248
Authors:
Cavallaro, R
Mistretta, P
Cocchi, F
Manzato, M
Smeraldi, E
Citation: R. Cavallaro et al., Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia, HUM PSYCHOP, 16(6), 2001, pp. 439-448
Authors:
Zanardi, R
Artigas, F
Moresco, R
Colombo, C
Messa, C
Gobbo, C
Smeraldi, E
Fazio, F
Citation: R. Zanardi et al., Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study, J CL PSYCH, 21(1), 2001, pp. 53-58
Authors:
Perna, G
Bertani, A
Caldirola, D
Smeraldi, E
Bellodi, L
Citation: G. Perna et al., A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study, PHARMACOPS, 34(3), 2001, pp. 85-90
Authors:
Serretti, A
Lilli, R
Lorenzi, C
Lattuada, E
Smeraldi, E
Citation: A. Serretti et al., DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: A study on 2,011 affected subjects, AM J MED G, 105(3), 2001, pp. 283-290
Authors:
Zanardi, R
Serretti, A
Rossini, D
Franchini, L
Cusin, C
Lattuada, E
Dotoli, D
Smeraldi, E
Citation: R. Zanardi et al., Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression, BIOL PSYCHI, 50(5), 2001, pp. 323-330
Authors:
Souery, D
Van Gestel, S
Massat, I
Blairy, S
Adolfsson, R
Blackwood, D
Del-Favero, J
Dikeos, D
Jakovljevic, M
Kaneva, R
Lattuada, E
Lerer, B
Lilli, L
Milanova, V
Muir, W
Nothen, M
Oruc, L
Papadimitriou, G
Propping, P
Schulze, T
Serretti, A
Shapira, B
Smeraldi, E
Stefanis, C
Thomson, M
Van Broeckhoven, C
Mendlewicz, J
Citation: D. Souery et al., Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A multicenter association study, BIOL PSYCHI, 49(5), 2001, pp. 405-409
Authors:
Battaglia, M
Bertella, S
Ogliari, A
Bellodi, L
Smeraldi, E
Citation: M. Battaglia et al., Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder, ARCH G PSYC, 58(2), 2001, pp. 114-119
Authors:
Bellodi, L
Cavallini, MC
Bertelli, S
Chiapparino, D
Riboldi, C
Smeraldi, E
Citation: L. Bellodi et al., Morbidity risk for obsessive-compulsive spectrum disorders in first-degreerelatives of patients with eating disorders, AM J PSYCHI, 158(4), 2001, pp. 563-569
Authors:
Perez, J
Tardito, D
Mori, S
Racagni, G
Smeraldi, E
Zanardi, R
Citation: J. Perez et al., Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment, BIPOL DIS, 2(1), 2000, pp. 27-36
Authors:
Serretti, A
Lattuada, E
Lorenzi, C
Lilli, R
Smeraldi, E
Citation: A. Serretti et al., Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses, MOL PSYCHI, 5(3), 2000, pp. 270-274
Authors:
Moresco, RM
Colombo, C
Fazio, F
Bonfanti, A
Lucignani, G
Messa, C
Gobbo, C
Galli, L
Del Sole, A
Lucca, A
Smeraldi, E
Citation: Rm. Moresco et al., Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a pet study, NEUROIMAGE, 12(4), 2000, pp. 452-465
Authors:
Serretti, A
Lilli, R
Lorenzi, C
Smeraldi, E
Citation: A. Serretti et al., Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia, SCHIZOPHR R, 43(2-3), 2000, pp. 161-162
Authors:
Zanardi, R
Benedetti, F
Di Bella, D
Catalano, M
Smeraldi, E
Citation: R. Zanardi et al., Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene, J CL PSYCH, 20(1), 2000, pp. 105-107
Authors:
Tzanakaki, M
Guazzelli, M
Nimatoudis, I
Zissis, NP
Smeraldi, E
Rizzo, F
Citation: M. Tzanakaki et al., Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia (vol 15, pg 29, 2000), INT CLIN PS, 15(2), 2000, pp. 120-120